ARMN

Aris Mining Corp

NYSE · Gold and Silver Ores · Inc. A1 · CIK 0001964504
Vol
Exchange NYSE·Sector Gold and Silver Ores·Inc. A1·CIK 0001964504

Analyst Ratings

Historical distribution91% buy · 11 analysts · last covering-analyst action Sep 2025
2Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Sep 4, 2025 Canaccord Genuity MAINTAIN Buy → Buy

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Sep 2025): 91% buy across 11 analysts — 2 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2025-12-31
$0.00 $0.00 $0.00 $0.3B 96.8%
Next Q
$0.00 $0.00 $0.00 $0.0B
Next FY
2026-12-31
$0.00 $0.00 $0.00 $1.5B 64.7%
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.9B 80.3%
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Sep 4, 2025 Canaccord Genuity MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262810091%
May 1, 20262810091%
Apr 1, 20262810091%
Mar 1, 20262710090%
Feb 1, 20262810091%
Jan 1, 20262810091%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.